Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.58 USD | +2.87% | +5.29% | +110.59% |
04-25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M 1.96B |
---|---|---|---|---|---|
Net income 2022 | -9M -721M | Net income 2023 | -5M -400M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M 3.37B | Net cash position 2023 | 37.15M 2.97B | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
1 day | +2.87% | ||
1 week | +5.29% | ||
Current month | +103.41% | ||
1 month | +104.57% | ||
3 months | +112.46% | ||
6 months | +91.44% | ||
Current year | +110.59% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 30/09/06 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 09/05/21 |
Sharon Perry
LAW | General Counsel | - | 31/12/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 15/02/17 |
Robert Conway
CHM | Chairman | 70 | 02/09/13 |
Linda Grais
BRD | Director/Board Member | 68 | 30/04/07 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 3.58 | +2.87% | 85,337 |
25/04/24 | 3.48 | -4.13% | 54,151 |
24/04/24 | 3.63 | -0.55% | 97,762 |
23/04/24 | 3.65 | +5.80% | 211,848 |
22/04/24 | 3.45 | +1.47% | 294,997 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotes1st Jan change | Capi. | |
---|---|---|
+110.59% | 51.91M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ABIO Stock